Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics

J N P Zwemmer1, J Berkhof, J A Castelijns

  • 1Department of Neurology, MS Center, VU University Medical Center, Amsterdam, The Netherlands. jnp.zwemmer@vumc.nl

Multiple Sclerosis (Houndmills, Basingstoke, England)
|November 8, 2006
PubMed
Abstract

Insights

Magnetic resonance imaging (MRI) can classify multiple sclerosis (MS) patients into subgroups based on lesion confluency and neuronal loss. This MRI-based classification may help identify patients with cognitive deficits.

Area of Science:

  • Neurology
  • Radiology
  • Biostatistics

Background:

  • Multiple sclerosis (MS) exhibits significant disease heterogeneity, complicating patient classification.
  • Current MS classification relies on clinical features, with pathological and group-level MRI signatures emerging.
  • A method for classifying individual MS patients using only MRI characteristics is lacking.

Purpose of the Study:

  • To determine if quantitative and qualitative MRI characteristics can classify MS patients into distinct subgroups.
  • To assess associations between identified MRI-based subgroups and clinical/laboratory characteristics.

Main Methods:

  • Brain and spinal cord MRI scans from 50 MS patients were analyzed for 21 quantitative and qualitative features.
  • Latent class analysis (LCA) was employed to identify patient subgroups.
  • Demographic, clinical, and laboratory data were compared across identified subgroups.

Main Results:

  • LCA identified two MS patient subgroups primarily differentiated by lesion confluency and MRI evidence of neuronal loss.
  • Subgroups showed comparable demographics and disease characteristics, except for cognitive deficits.
  • No significant correlations were found between MRI-based subgroups and laboratory measures.

Conclusions:

  • Latent class analysis provides a feasible method for subgrouping MS patients based on MRI characteristics.
  • The identified MRI-based classification requires further validation in larger, independent cohorts for reproducibility and prognostic relevance.